Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.

The native capsular polysaccharide of type III group B Streptococcus elicits a specific antibody response in only 60% of nonimmune human subjects. To enhance the immunogenicity of this polysaccharide, we coupled the type III polysaccharide to tetanus toxoid. Prior to coupling, aldehyde groups were i...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	J Clin Invest
Egile Nagusiak:	Wessels, M R, Paoletti, L C, Kasper, D L, DiFabio, J L, Michon, F, Holme, K, Jennings, H J
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Clinical Investigation 1990
Gaiak:	Research Article
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296886/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2243123/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114858
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!